Hysteroscopic surgery
Conditions
Interventions
A group:Sufentanil 0.1ug/kg was administered intravenously
B group:Sufentanil 0.15ug/kg was administered intravenously
Sponsors
The Third Affiliated Hospital of Guangzhou University of Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1.Patients aged 18–70 years; 2.American Society of Anesthesiologists (ASA) physical status I or II; 3.Body mass index(BMI) of 18–28 kg/m2; 4.Informed consent for the study was obtained from the participants or their family members;
Exclusion criteria
Exclusion criteria: 1.Allergic to the anesthetic ingredients used in the study; 2.Combined with severe heart, lung, liver, kidney and other organ insufficiencies; 3.Combined with mental system diseases; 4.Prolonged use of sedative or analgesic drugs;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of body movements during surgery;Incidence of respiratory depression during surgery?Pulse Oxygen Saturation (SpO2) < 90%?; | — |
Secondary
| Measure | Time frame |
|---|---|
| SBP,DBP,MAP,HR and MOAA/S score before anesthesia induction (T0), after anesthesia induction (T1), at cervical dilation (T2) and at postoperative recovery (T3);Number of additional episodes of ciprofol during surgery, total amount of ciprofol, duration of surgery, and time to awakening;Occurrence of intraoperative and postoperative adverse events and postoperative pain score score (VAS score), where adverse events include hypotension, bradycardia, dizziness, nausea and vomiting.; | — |
Countries
China
Contacts
Public ContactLin Baojia
The Third Affiliated Hospital of Guangzhou University of Chinese Medicine
Outcome results
None listed